Annual Revenue
$233.66 M
+$230.88 M+8290.02%
31 December 2023
Summary:
TG Therapeutics annual revenue is currently $233.66 million, with the most recent change of +$230.88 million (+8290.02%) on 31 December 2023. During the last 3 years, it has risen by +$233.51 million (+153625.00%). TGTX annual revenue is now at all-time high.TGTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$83.88 M
+$10.41 M+14.17%
30 September 2024
Summary:
TG Therapeutics quarterly revenue is currently $83.88 million, with the most recent change of +$10.41 million (+14.17%) on 30 September 2024. Over the past year, it has dropped by -$81.94 million (-49.41%). TGTX quarterly revenue is now -49.41% below its all-time high of $165.81 million, reached on 30 September 2023.TGTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$264.79 M
-$81.94 M-23.63%
30 September 2024
Summary:
TG Therapeutics TTM revenue is currently $264.79 million, with the most recent change of -$81.94 million (-23.63%) on 30 September 2024. Over the past year, it has increased by +$75.02 million (+39.53%). TGTX TTM revenue is now -23.63% below its all-time high of $346.73 million, reached on 30 June 2024.TGTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8290.0% | -49.4% | +39.5% |
| 3 y3 years | +10000.0% | +4032.0% | +5909.8% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
TGTX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -49.4% | >+9999.0% | -23.6% | +9411.1% |
| 5 y | 5 years | at high | >+9999.0% | -49.4% | >+9999.0% | -23.6% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -49.4% | -23.6% | >+9999.0% |
TG Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $83.88 M(+14.2%) | $264.79 M(-23.6%) |
| June 2024 | - | $73.47 M(+15.7%) | $346.73 M(+19.8%) |
| Mar 2024 | - | $63.47 M(+44.4%) | $289.33 M(+23.8%) |
| Dec 2023 | $233.66 M(+8290.0%) | $43.97 M(-73.5%) | $233.66 M(+23.1%) |
| Sept 2023 | - | $165.81 M(+931.6%) | $189.77 M(+689.0%) |
| June 2023 | - | $16.07 M(+106.0%) | $24.05 M(+180.6%) |
| Mar 2023 | - | $7.80 M(+9653.8%) | $8.57 M(+207.9%) |
| Dec 2022 | $2.79 M(-58.4%) | $80.00 K(-14.9%) | $2.78 M(-44.6%) |
| Sept 2022 | - | $94.00 K(-84.2%) | $5.03 M(-27.8%) |
| June 2022 | - | $594.00 K(-70.5%) | $6.96 M(-12.0%) |
| Mar 2022 | - | $2.02 M(-13.1%) | $7.91 M(+18.3%) |
| Dec 2021 | $6.69 M(+4300.7%) | $2.32 M(+14.3%) | $6.69 M(+51.8%) |
| Sept 2021 | - | $2.03 M(+31.4%) | $4.41 M(+82.5%) |
| June 2021 | - | $1.54 M(+94.8%) | $2.41 M(+166.2%) |
| Mar 2021 | - | $793.00 K(+1986.8%) | $907.00 K(+496.7%) |
| Dec 2020 | $152.00 K(0.0%) | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Sept 2020 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| June 2020 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Mar 2020 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Dec 2019 | $152.00 K(0.0%) | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Sept 2019 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| June 2019 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Mar 2019 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Dec 2018 | $152.00 K(0.0%) | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Sept 2018 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| June 2018 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Mar 2018 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Dec 2017 | $152.00 K(0.0%) | $38.00 K(0.0%) | $152.00 K(+0.2%) |
| Sept 2017 | - | $38.00 K(0.0%) | $151.70 K(-0.1%) |
| June 2017 | - | $38.00 K(0.0%) | $151.80 K(-0.1%) |
| Mar 2017 | - | $38.00 K(+0.8%) | $151.90 K(-0.1%) |
| Dec 2016 | $152.00 K(-0.3%) | $37.70 K(-1.0%) | $152.00 K(-0.3%) |
| Sept 2016 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| June 2016 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Mar 2016 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $152.40 K(0.0%) | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Sept 2015 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| June 2015 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Mar 2015 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Dec 2014 | $152.40 K(0.0%) | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Sept 2014 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| June 2014 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Mar 2014 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Dec 2013 | $152.40 K(+702.1%) | $38.10 K(0.0%) | $152.40 K(+14.3%) |
| Sept 2013 | - | $38.10 K(0.0%) | $133.30 K(+40.0%) |
| June 2013 | - | $38.10 K(0.0%) | $95.20 K(+66.7%) |
| Mar 2013 | - | $38.10 K(+100.5%) | $57.10 K(+200.5%) |
| Dec 2012 | $19.00 K(-99.3%) | $19.00 K(>+9900.0%) | $19.00 K(-99.7%) |
| Dec 2001 | $2.71 M(-49.4%) | - | - |
| June 2001 | - | $0.00(-100.0%) | $5.71 M(-20.1%) |
| Mar 2001 | - | $2.71 M(+40.8%) | $7.15 M(+33.3%) |
| Dec 2000 | $5.36 M(+346.6%) | $1.93 M(+79.6%) | $5.36 M(+23.7%) |
| Sept 2000 | - | $1.07 M(-25.2%) | $4.33 M(+21.7%) |
| June 2000 | - | $1.43 M(+55.0%) | $3.56 M(+67.5%) |
| Mar 2000 | - | $925.50 K(+2.8%) | $2.13 M(+77.1%) |
| Dec 1999 | $1.20 M(-52.0%) | $900.00 K(+200.0%) | $1.20 M(+300.0%) |
| Sept 1999 | - | $300.00 K(>+9900.0%) | $300.00 K(+200.0%) |
| June 1999 | - | $0.00(0.0%) | $100.00 K(-96.2%) |
| Mar 1999 | - | $0.00(-100.0%) | $2.60 M(-3.7%) |
| Dec 1998 | $2.50 M(+2400.0%) | - | - |
| Sept 1998 | - | $100.00 K(-96.0%) | $2.70 M(0.0%) |
| June 1998 | - | $2.50 M(+2400.0%) | $2.70 M(+800.0%) |
| Mar 1998 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1997 | $100.00 K(0.0%) | - | - |
| Sept 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| June 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1996 | $100.00 K | - | - |
| Sept 1996 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| June 1996 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is TG Therapeutics annual revenue?
- What is the all time high annual revenue for TG Therapeutics?
- What is TG Therapeutics annual revenue year-on-year change?
- What is TG Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for TG Therapeutics?
- What is TG Therapeutics quarterly revenue year-on-year change?
- What is TG Therapeutics TTM revenue?
- What is the all time high TTM revenue for TG Therapeutics?
- What is TG Therapeutics TTM revenue year-on-year change?
What is TG Therapeutics annual revenue?
The current annual revenue of TGTX is $233.66 M
What is the all time high annual revenue for TG Therapeutics?
TG Therapeutics all-time high annual revenue is $233.66 M
What is TG Therapeutics annual revenue year-on-year change?
Over the past year, TGTX annual revenue has changed by +$230.88 M (+8290.02%)
What is TG Therapeutics quarterly revenue?
The current quarterly revenue of TGTX is $83.88 M
What is the all time high quarterly revenue for TG Therapeutics?
TG Therapeutics all-time high quarterly revenue is $165.81 M
What is TG Therapeutics quarterly revenue year-on-year change?
Over the past year, TGTX quarterly revenue has changed by -$81.94 M (-49.41%)
What is TG Therapeutics TTM revenue?
The current TTM revenue of TGTX is $264.79 M
What is the all time high TTM revenue for TG Therapeutics?
TG Therapeutics all-time high TTM revenue is $346.73 M
What is TG Therapeutics TTM revenue year-on-year change?
Over the past year, TGTX TTM revenue has changed by +$75.02 M (+39.53%)